Generation of functionally competent and durable engineered blood vessels from human induced pluripotent stem cells
暂无分享,去创建一个
R. Jain | D. Fukumura | D. Scadden | W. Kamoun | P. Au | L. Daheron | S. Liao | D. Duda | Xiaoxing Han | R. Schäfer | Rekha Samuel | Ana L. Batista | C. Buecker | Trupti D. Vardam
[1] T. Myers,et al. Transgene-free iPSCs generated from small volume peripheral blood nonmobilized CD34+ cells. , 2013, Blood.
[2] G. Daley,et al. Reprogrammed cells for disease modeling and regenerative medicine. , 2013, Annual review of medicine.
[3] D. Srivastava,et al. Limited Gene Expression Variation in Human Embryonic Stem Cell and Induced Pluripotent Stem Cell‐Derived Endothelial Cells , 2013, Stem cells.
[4] W. Stanford,et al. Modeling and Rescue of the Vascular Phenotype of Williams‐Beuren Syndrome in Patient Induced Pluripotent Stem Cells , 2013, Stem cells translational medicine.
[5] T. Cantz,et al. Engineered MSCs from Patient-Specific iPS Cells. , 2013, Advances in biochemical engineering/biotechnology.
[6] G. Daley,et al. Functional vascular smooth muscle cells derived from human induced pluripotent stem cells via mesenchymal stem cell intermediates. , 2012, Cardiovascular research.
[7] David G. Armstrong,et al. Long-Term Prognosis of Diabetic Foot Patients and Their Limbs , 2012, Diabetes Care.
[8] Xuan Sun,et al. Characterization and comparison of embryonic stem cell-derived KDR+ cells with endothelial cells. , 2012, Microvascular research.
[9] Jiannis Ragoussis,et al. Direct reprogramming of fibroblasts into endothelial cells capable of angiogenesis and reendothelialization in tissue-engineered vessels , 2012, Proceedings of the National Academy of Sciences.
[10] A. Reinisch,et al. Transplantation and Tracking of Human-Induced Pluripotent Stem Cells in a Pig Model of Myocardial Infarction: Assessment of Cell Survival, Engraftment, and Distribution by Hybrid Single Photon Emission Computed Tomography/Computed Tomography of Sodium Iodide Symporter Transgene Expression , 2012, Circulation.
[11] I. Weissman,et al. Isolation of primitive endoderm, mesoderm, vascular endothelial and trophoblast progenitors from human pluripotent stem cells , 2012, Nature Biotechnology.
[12] A. Icks,et al. Long-Term Prognosis of Diabetic Foot Patients and Their Limbs Amputation and death over the course of a decade , 2012 .
[13] Yoji Nagai,et al. Regenerative medicine in critical limb ischemia. , 2012, Journal of atherosclerosis and thrombosis.
[14] Sanjiv S Gambhir,et al. Endothelial Cells Derived From Human iPSCS Increase Capillary Density and Improve Perfusion in a Mouse Model of Peripheral Arterial Disease , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[15] R. Jain,et al. Engineered blood vessel networks connect to host vasculature via wrapping-and-tapping anastomosis. , 2011, Blood.
[16] G. Daley,et al. Induced pluripotent stem cells for modelling human diseases , 2011, Philosophical Transactions of the Royal Society B: Biological Sciences.
[17] P. Carmeliet,et al. Molecular mechanisms and clinical applications of angiogenesis , 2011, Nature.
[18] A. Khera,et al. Forecasting the Future of Cardiovascular Disease in the United States: A Policy Statement From the American Heart Association , 2011, Circulation.
[19] Jinqiu Zhang,et al. A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects. , 2011, Cell stem cell.
[20] D. Mooney,et al. Modulating Notch signaling to enhance neovascularization and reperfusion in diabetic mice. , 2010, Biomaterials.
[21] A. Avogaro,et al. Improved Function of Circulating Angiogenic Cells Is Evident in Type 1 Diabetic Islet‐Transplanted Patients , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[22] Alexander Meissner,et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. , 2010, Cell stem cell.
[23] S. Gerecht,et al. Engineering blood vessels using stem cells: innovative approaches to treat vascular disorders , 2010, Expert review of cardiovascular therapy.
[24] Milton Waner,et al. Reversal of hyperglycemia in diabetic mouse models using induced-pluripotent stem (iPS)-derived pancreatic β-like cells , 2010, Proceedings of the National Academy of Sciences.
[25] Dai Fukumura,et al. Simultaneous measurement of RBC velocity, flux, hematocrit and shear rate in tumor vascular networks , 2010, Nature Methods.
[26] Hsu-hsin Chen,et al. A murine ESC-like state facilitates transgenesis and homologous recombination in human pluripotent stem cells. , 2010, Cell stem cell.
[27] Kwang-Soo Kim,et al. Hemangioblastic Derivatives from Human Induced Pluripotent Stem Cells Exhibit Limited Expansion and Early Senescence , 2010, Stem cells.
[28] Nikica Zaninovic,et al. Expansion and maintenance of human embryonic stem cell–derived endothelial cells by TGFβ inhibition is Id1 dependent , 2010, Nature Biotechnology.
[29] I. Weissman,et al. Functional and Transcriptional Characterization of Human Embryonic Stem Cell-Derived Endothelial Cells for Treatment of Myocardial Infarction , 2009, PloS one.
[30] J. P. McCoy,et al. Neuropilin-1 Identifies Endothelial Precursors in Human and Murine Embryonic Stem Cells Before CD34 Expression , 2009, Circulation.
[31] George Q. Daley,et al. Disease-Specific Induced Pluripotent Stem Cells , 2008, Cell.
[32] Paul H Lerou,et al. Generation of human-induced pluripotent stem cells , 2008, Nature Protocols.
[33] Dai Fukumura,et al. Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature. , 2008, Blood.
[34] Chad A. Cowan,et al. Marked differences in differentiation propensity among human embryonic stem cell lines , 2008, Nature Biotechnology.
[35] Dai Fukumura,et al. Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels. , 2008, Blood.
[36] T. Ichisaka,et al. Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.
[37] S. Yamanaka. Strategies and new developments in the generation of patient-specific pluripotent stem cells. , 2007, Cell stem cell.
[38] R. Jain,et al. Endothelial cells derived from human embryonic stem cells form durable blood vessels in vivo , 2007, Nature Biotechnology.
[39] D. Mooney,et al. Host Immune Competence and Local Ischemia Affects the Functionality of Engineered Vasculature , 2007, Microcirculation.
[40] R. Jain,et al. Small blood vessel engineering. , 2007, Methods in molecular medicine.
[41] Dai Fukumura,et al. Tissue engineering: Creation of long-lasting blood vessels , 2004, Nature.
[42] Frank J T Staal,et al. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. , 2004, Diabetes.
[43] J. Waltenberger. Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications. , 2001, Cardiovascular research.
[44] R K Jain,et al. Quantitation and physiological characterization of angiogenic vessels in mice: effect of basic fibroblast growth factor, vascular endothelial growth factor/vascular permeability factor, and host microenvironment. , 1996, The American journal of pathology.
[45] R K Jain,et al. Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. , 1994, Cancer research.